Program

Moderator

 2026/11/15 12:10-13:10　 Room ROOM 402C
  • 午餐議程-衛采製藥:
    衛采製藥股份有限公司
衛采製藥股份有限公司
  • Time
  • Topic
  • Speaker
  • Moderator
  • 12:15-13:00
  • From Amyloid Clearance to Sustained Clinical Benefit: Clinical and Real-World Evidence Supporting Continuous Treatment with Lecanemab
  • SPEAKER:  Pi-Shan  Sung
    宋碧姍
     Taiwan (台灣)
  • MODERATOR:  Chaur-Jong  Hu
    胡朝榮
     Taiwan (台灣)
Taiwan (台灣)
  • Chaur-Jong  Hu
  • MD
  • Consultant Neurologist, Shuang Ho Hospital, Taipei Medical University
    Dean , College of Medicine, Taipei Medical University